| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |